Showing results (471-480 of 742) with videos related to
Sort By:
Pageof 75
HIV Medicine|January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.Nucleic Acids Research|May 1, 2012
A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNADavid J Hooker, Masqura Mobarok, Jenny L Anderson, et al.Journal of Virus Eradication|October 24, 2017
HIV cure research: print and online media reporting in AustraliaJennifer Power, Bianca Fileborn, Gary W Dowsett, et al.Scientific Reports|November 3, 2016
Fxyd2 regulates Aδ- and C-fiber mechanosensitivity and is required for the maintenance of neuropathic painStéphanie Ventéo, Sophie Laffray, Christiane Wetzel, et al.Journal of Virology|February 4, 2025
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoirRachel D Pascoe, Youry Kim, Ajantha Rhodes, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infectionSharon R Lewin, Ruy M Ribeiro, Gilbert R Kaufmann, et al.Cell Reports|October 13, 2016
Hypofunctional TrkA Accounts for the Absence of Pain Sensitization in the African Naked Mole-RatDamir Omerbašić, Ewan St J Smith, Mirko Moroni, et al.Brain : a Journal of Neurology|December 18, 2007
Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological studyKristina Simonyan, Fernanda Tovar-Moll, John Ostuni, et al.Virology|May 27, 2005
Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndromeLachlan Gray, Jasminka Sterjovski, Melissa Churchill, et al.Scientific Reports|November 22, 2019
Structural basis for phospholipase A<sub>2</sub>-like toxin inhibition by the synthetic compound Varespladib (LY315920)Guilherme H M Salvador, Antoniel A S Gomes, Wendy Bryan-Quirós, et al.Pageof 75